BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7030882)

  • 1. Role of hormones including diethylstibestrol (DES) in the pathogenesis of cervical and vaginal intraepithelial neoplasia.
    Robboy SJ; Truslow GY; Anton J; Richart RM
    Gynecol Oncol; 1981 Oct; 12(2 Pt 2):S98-110. PubMed ID: 7030882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project.
    Robboy SJ; Szyfelbein WM; Goellner JR; Kaufman RH; Taft PD; Richard RM; Gaffey TA; Prat J; Virata R; Hatab PA; McGorray SP; Noller KL; Townsend D; Labarthe D; Barnes AB
    Am J Obstet Gynecol; 1981 Jul; 140(5):579-86. PubMed ID: 7195652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project.
    Robboy SJ; Noller KL; O'Brien P; Kaufman RH; Townsend D; Barnes AB; Gundersen J; Lawrence WD; Bergstrahl E; McGorray S
    JAMA; 1984 Dec; 252(21):2979-83. PubMed ID: 6502858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In utero exposure to DES. Evaluation and followup of 199 women.
    Fowler WC; Edelman DA
    Obstet Gynecol; 1978 Apr; 51(4):459-63. PubMed ID: 662229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six years' experience with screening of a diethylstilbestrol-exposed population.
    Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
    Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract.
    Troisi R; Hatch EE; Palmer JR; Titus L; Robboy SJ; Strohsnitter WC; Herbst AL; Adam E; Hyer M; Hoover RN
    Am J Obstet Gynecol; 2016 Sep; 215(3):322.e1-8. PubMed ID: 26979629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
    Barclay DL
    J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix.
    Herbst AL; Cole P; Colton T; Robboy SJ; Scully RE
    Am J Obstet Gynecol; 1977 May; 128(1):43-50. PubMed ID: 851158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of the adolescent girl exposed in utero to DES.
    Gerbie MV
    Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diethylstilbestrol (DES) update. A message from the DESAD Project.
    Powers D
    Wis Med J; 1985 Feb; 84(2):11-4. PubMed ID: 3984375
    [No Abstract]   [Full Text] [Related]  

  • 12. Squamous cell dysplasia and carcinoma in situ of the cervix and vagina after prenatal exposure to diethylstilbestrol.
    Robboy SJ; Keh PC; Nickerson RJ; Helmanis EK; Prat J; Szyfelbein WM; Taft PD; Barnes AB; Scully RE; Welch WR
    Obstet Gynecol; 1978 May; 51(5):528-35. PubMed ID: 652199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States).
    Hatch EE; Herbst AL; Hoover RN; Noller KL; Adam E; Kaufman RH; Palmer JR; Titus-Ernstoff L; Hyer M; Hartge P; Robboy SJ
    Cancer Causes Control; 2001 Nov; 12(9):837-45. PubMed ID: 11714112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project.
    Jefferies JA; Robboy SJ; O'Brien PC; Bergstralh EJ; Labarthe DR; Barnes AB; Noller KL; Hatab PA; Kaufman RH; Townsend DE
    Am J Obstet Gynecol; 1984 Jan; 148(1):59-66. PubMed ID: 6691382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current status of the DES-exposed population.
    Herbst AL
    Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
    Vessey MP; Lawless M; McPherson K; Yeates D
    Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous neoplasia in DES-exposed women.
    Stafl A
    Obstet Gynecol Surv; 1979 Nov; 34(11):847. PubMed ID: 523033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of the genital tract following stilbestrol exposure in utero.
    Kurman RJ
    Recent Results Cancer Res; 1979; 66():161-74. PubMed ID: 373028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal and cervical squamous cell dysplasia in women exposed to diethylstilbestrol in utero.
    Burke L; Antonioli D; Rosen S
    Am J Obstet Gynecol; 1978 Nov; 132(5):537-44. PubMed ID: 717453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous cell carcinoma in situ of the vagina and cervix after intrauterine DES exposure.
    Veridiano NP; Tancer ML; Weiner EA
    Obstet Gynecol; 1978 Jul; 52(1 Suppl):30S-33S. PubMed ID: 683639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.